Key Insights

Highlights

Success Rate

83% trial completion

Published Results

34 trials with published results (12%)

Research Maturity

75 completed trials (26% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

5.3%

15 terminated out of 284 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

6%

18 trials in Phase 3/4

Results Transparency

45%

34 of 75 completed with results

Key Signals

34 with results83% success15 terminated

Data Visualizations

Phase Distribution

205Total
Not Applicable (107)
Early P 1 (10)
P 1 (34)
P 2 (36)
P 3 (16)
P 4 (2)

Trial Status

Recruiting102
Completed75
Active Not Recruiting65
Terminated15
Withdrawn11
Not Yet Recruiting7

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 75 completed trials

Clinical Trials (284)

Showing 20 of 20 trials
NCT05642611Phase 3RecruitingPrimary

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

NCT07278739Not ApplicableNot Yet RecruitingPrimary

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

NCT05075759Not ApplicableActive Not Recruiting

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer

NCT05101213Phase 1Recruiting

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT04592250Active Not Recruiting

Financial Toxicity in Cancer Patients

NCT06126276Phase 2Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT04829539Phase 3Recruiting

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

NCT05012124Not ApplicableTerminated

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

NCT04196972Not ApplicableActive Not Recruiting

Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians

NCT03168737Phase 1Active Not Recruiting

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

NCT06351371Phase 2Active Not RecruitingPrimary

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

NCT04565665Phase 1Recruiting

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04314401Active Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT06009926Phase 2Active Not Recruiting

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

NCT04387656Active Not Recruiting

NCI COVID-19 in Cancer Patients, NCCAPS Study

NCT04955808Suspended

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

NCT02496208Phase 1Active Not Recruiting

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

NCT06198010Not ApplicableRecruiting

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

NCT06995898Not ApplicableRecruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT05554367Phase 2Active Not Recruiting

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Scroll to load more

Research Network

Activity Timeline